Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Treace Medical Concepts, Inc. (TMCI) Shareholders — Neutral
TMCI Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=148026&wire=1 or contact Joseph E. Levi, Esq.

Carnival Corporation & plc Announces the Redemption of Existing $993 Million 7.625% Senior Unsecured Notes due 2026 and Launch of New Senior Unsecured Notes Offering for Interest Expense Reduction — Neutral
CUK PRNewsWire — May 12, 2025MIAMI , May 12, 2025 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the "Company") commenced a private offering (the "Notes Offering") of new senior unsecured notes in an aggregate principal amount of $1.0 billion, expected to mature in 2031 (the "Notes"), to refinance the Company's $993 million 7.625% senior unsecured notes due 2026 (the "2026 Unsecured Notes"), expecting to reduce interest expense and manage its future debt maturities. In addition, the indenture that will govern the Notes is expected to have investment grade-style covenants.

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 — Neutral
ICCC GlobeNewsWire — May 12, 2025PORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2025 after the market closes on Wednesday, May 14, 2025. The Company is planning to host a conference call the next morning, Thursday, May 15, 2025, at 9:00 AM ET to review the unaudited financial results.

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 — Neutral
OMER Business Wire — May 12, 2025SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) today announced that it has entered into exchange agreements (the “Exchange Agreements”) with a limited number of investors who are holders of the Company's 5.25% Convertible Senior Notes due 2026 (the “2026 Convertible Notes”) to exchange, on a one-for-one basis, $70.5 million aggregate principal amount of the 2026 Convertible Notes for newly issued 9.50% Convertible Senior Notes due 2029, with a conversion.

CVNA or LAD: Which Auto Retailer Has the Edge for Future Gains? — Positive
CVNA LAD Zacks Investment Research — May 12, 2025Carvana and Lithia are two big auto retailers with different strategies but only one stands out as the clear winner in a tariff-hit, margin-tightening market.

United Parks & Resorts (PRKS) Reports Q1 Loss, Lags Revenue Estimates — Negative
PRKS Zacks Investment Research — May 12, 2025United Parks & Resorts (PRKS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.17 per share a year ago.

Iovance Biotherapeutics' (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman — Neutral
IOVA GlobeNewsWire — May 12, 2025SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- In a dramatic turn for Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), investors watched the company's shares plunge nearly 44% on May 9, 2025, after the San Carlos-based cell therapy pioneer reported a first-quarter revenue miss that sharply contradicted earlier upbeat assurances from management.

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial — Neutral
MBRX GlobeNewsWire — May 12, 2025Adds nine additional countries to the Company's ongoing pivotal Phase 3 trial; Authorization granted in all EU countries requested

Fox recorded a big gain in fiscal third-quarter revenue from its broadcast of the Super Bowl while surging costs cut into its earnings.

Here's Why Investors Should Consider Retaining Carlisle Stock Now — Positive
CSL Zacks Investment Research — May 12, 2025CSL benefits from strength in the non-residential construction market, acquisitions and shareholder-friendly policies. Soft residential market and high operating expenses remain concerns.

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates — Negative
IBRX Zacks Investment Research — May 12, 2025ImmunityBio (IBRX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.20 per share a year ago.

Redwire Corporation (RDW) Reports Q1 Loss, Misses Revenue Estimates — Neutral
RDW Zacks Investment Research — May 12, 2025Redwire Corporation (RDW) came out with a quarterly loss of $0.20 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.17 per share a year ago.

Local Bounti to Release First Quarter 2025 Financial Results on Wednesday, May 14, 2025 — Neutral
LOCL PRNewsWire — May 12, 2025HAMILTON, Mont. , May 12, 2025 /PRNewswire/ -- Local Bounti Corporation (NYSE: LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company, today announced it will release its financial results for the fiscal first quarter ended March 31, 2025 before the market opens on Wednesday, May 14, 2025.

First Pacific to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th — Neutral
DB GlobeNewsWire — May 12, 2025Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Belite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th — Neutral
BLTE GlobeNewsWire — May 12, 2025Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Willamette Valley Vineyards Appoints Wine.com Founder Michael Osborn as Chief Executive Officer — Neutral
WVVI WVVIP PRNewsWire — May 12, 2025WVV Founder Jim Bernau Continues as Chairman and President, Marking Strategic Leadership Succession SALEM HILLS, Ore., May 12, 2025 /PRNewswire/ -- Willamette Valley Vineyards (NASDAQ: WVVI, WVVIP), one of Oregon's most respected estate wineries, announced today that Mike Osborn, founder of Wine.com, has been named Chief Executive Officer, effective immediately.

Berger Montague Reminds Zynex (NASDAQ: ZYXI) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by May 19, 2025 — Neutral
ZYXI PRNewsWire — May 12, 2025PHILADELPHIA , May 12, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) on behalf of purchasers of Zynex securities between March 13, 2023 through March 11, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired ZYNEX securities during the Class Period may, no later than MAY 19, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Barnes & Noble Education Announces Surge in New Campus Store Partnerships — Neutral
BNED GlobeNewsWire — May 12, 2025BASKING RIDGE, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE: BNED), a leading solutions provider for the education industry, today announced a wave of new campus store partnerships with colleges and universities across the country.

Plymouth Industrial REIT focuses on the Golden Triangle, owning nearly 200 buildings with high occupancy but relies heavily on shareholder dilution for growth. The complex deal with Sixth Street, involving a $250 million investment and preferred equity issuance, complicates financials and raises concerns about capital allocation strategies. Despite appealing valuation metrics, including a low FFO multiple and high dividend yield, I remain cautious due to dated properties and expensive overhead.
